IGIMS IGIMS IGIMS IGIMS
IGIMS     
An Autonomous Institute under Government of Bihar & Statutory University created by an Act of State Legislature and recognized by UGC
COVID 19 GLOBAL MEDICAL ARTICLES
COVID-19 GLOBAL MEDICAL ARTICLES
1.

Epidemiology of Covid-19 in a Long-Term Care Facility in King County, Washington.

2.

The Invisible Hand — Medical Care during the Pandemic.

3.

Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.

4.

Real-Time Quantitative PCR Assays for Detection and Monitoring of Pathogenic Human Viruses in Immunosuppressed Pediatric Patients.

5.

Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR.

6.

A novel coronavirus outbreak of global health concern.

7.

Viral load of SARS-CoV-2 in clinical samples.

8.

Viral Load Kinetics of SARS-CoV-2 Infection in First Two Patients in Korea.

9.

SARSCoV-2 (Cell).

10.

Laboratory testing for coronavirus disease (COVID-19) in suspected human cases.

11.

Standard Operating Procedure For Detection of 2019 novel coronavirus (2019-nCoV) in suspected human cases by rRT-PCR : First Line Screening assay.

12. 

Severe acute respiratory illness surveillance for coronavirus disease 2019, India, 2020.

13. 

Corona Virus disease 2019 (COVID-19) Situation Report-80.

14.

Chloroquine and hydroxychloroquine in COVID-19.

15.

Early Transmission Dynamics in Wuhan, China, of Novel Coronavirus–Infected Pneumonia.

16.

Use of Hydroxychloroquine and Chloroquine During the COVID-19 Pandemic: What Every Clinician Should Know.

17.

How Sewage Could Reveal True Scale Of Coronavirus Outbreak.

18.

Guide to understand the 2019 NOVEL CORONAVIRUS.

19.

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

20.

Coronavirus disease 2019 (COVID-19) : The right clinical information, right where it's needed.

21.

Face masks for the public during the covid-19 crisis.

22.

Compassionate Use of Remdesivir for Patients with Severe Covid-19.

23.

A Shift on the Front Line.

24.

Disease Control, Civil Liberties, and Mass Testing — Calibrating Restrictions during the Covid-19 Pandemic. 

25. 

Not Dying Alone- Modern Compassionate Care in the COVID-19 Pandemic. 

26.

Drug Evaluation during the Covid-19 Pandemic.

27.

COVID-19, diabetes mellitus and ACE2: The conundrum.

28.

The FDA-approved Drug Ivermectin inhibits the replication of SARS-1 CoV-2 in vitro.

29.

Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19).

30.

Guidelines on Establishment of Virology Laboratory in Developing Countries.

31.

COVID-19 and the cardiovascular system.

32.

Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study.

33.

CT screening for early diagnosis of SARS-CoV-2 infection.

34.

Flooded by the torrent: the COVID-19 drug pipeline.

35.

COVID-19 in the USA: a question of time.

36.

Prediction models for diagnosis and prognosis in Covid-19.

37.

Prediction models for diagnosis and prognosis of covid-19 infection: systematic review and critical appraisal.

38.

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1.

39.

How to Obtain a Nasopharyngeal Swab Specimen.

40.

Guillain–Barré Syndrome Associated with SARS-CoV-2.

41.

Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients with COVID-19.

42.

Forecast of COVID-19 Case in India by Lockdown Patterns.

43.

Age-structured impact of social distancing on the COVID-19 epidemic in India.

44.

Dentistry and coronavirus (COVID-19) – moral decision-making.

45.

Universal Screening for SARS-CoV-2 in Women Admitted for Delivery.

46.

Prediction for COVID-19 Outbreak in India uing Epidemiological Models.

47.

The architecture of SARS-CoV-2 transcriptome.

48.

Universal Screening for SARS-CoV-2 in Women Admitted for Delivery.

49.

Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19.

50.

Ten Weeks to Crush the Curve.

51.

Myocarditis in a patient with COVID-19: a cause of raised troponin and ECG changes.

52.

Travel restrictions hampering COVID-19 response.

53.

Modelling can only tell us so much: politics explains the rest.

54.

The Penumbra: COVID-19 fault lines.

55.

India under COVID-19 lockdown.

56.

Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility.

57.

Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19.

58.

Covid-19 — A Reminder to Reason.

59.

Mild or Moderate Covid-19.

60.

Early dynamics of transmission and control of COVID-19: a mathematical modelling study.

61.

SARS-CoV-2: virus dynamics and host response.

62.
 
 
63.
 
 
64.
 
 
65.

Physician Burnout, Interrupted.

66.

Cardiovascular Disease, Drug Therapy,and Mortality in Covid-19.

67.

Observational Study of Hydroxychloroquine in Hospitalized Patients with Covid-19.

68.

Association between Angiotensin Blockade and Incidence of Influenza in the United Kingdom.

69.

Clasification of the cutaneous manifestations of COVID-19: a rapid prospective nationwide consensus study in Spain with 375 cases.

70.

What policy makers need to know about COVID-19 protective immunity.

71.

How to Discover Antiviral Drugs Quickly.

72.

PCR screening of asymptomatic healthcare workers at London hospital.

73.

Riding the coronacoaster of uncertainty.

74.

Estimates of the severity of coronavirus disease 2019: a model-based analysis.

75.

Controversies of renin–angiotensin system inhibition during the COVID-19 pandemic.

76.

Hypertension, renin–angiotensin–aldosterone system inhibition, and COVID-19.

77.

Interferon beta-1b for COVID-19.

78.

The art of medicine: Has COVID-19 subverted global health?

79.

Suppressing the Epidemic in New South Wales.

80.

Swabs Collected by Patients or Health Care Workers for SARS-CoV-2 Testing.

81.

Severe Covid-19: The Clinical Problem.

82.

COVID-19: Attacks the 1-Beta Chain of Hemoglobin and Captures the Porphyrin to Inhibit Human Heme Metabolism.

83.
84.

Men’s health: COVID-19 pandemic highlights need for overdue policy action.

85.

Solidarity in the wake of COVID-19: reimagining the International Health Regulations.

86.

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report.

87.

Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers.

Prof. (Dr.) S. K. Shahi                              Nodal Officer- COVID-19, IGIMS, Patna. 

 

 
Home l Contact Us l Privacy Policy l Terms of Use l RTI l Telephone Directory l News Clippings 1 l Recent Updates l Site Map l Opportunity l Training